NCT06852092View on ClinicalTrials.gov

Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

September 27, 2024

Study Completion Date

December 10, 2024

Conditions
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Interventions
DRUG

Carbon-14 labeled HSK39297

Dose A

Trial Locations (1)

Unknown

The Second Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT06852092 - Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects | Biotech Hunter | Biotech Hunter